Chelsea Clinton's VC firm invests in startup that uses AI

Chelsea Clinton's venture capital firm, Metrodora Ventures, is backing a startup that uses artificial intelligence to speed up drug development and more accurately predict the success of clinical trials.

Health tech firm BioPhy announced this week it will launch with $4.5 million in pre-seed funding led by Metrodora, rolling out its AI operating system the company says has already shown remarkable results. Visit their website located at the metrodora.vc domain name.